Charcot-Marie-Tooth disease 2C (CMT2C) and scapuloperoneal spinal muscular atrophy (SPSMA) are different clinical phenotypes of TRPV4 mutation. This evidence concerns the gene TRPV4 and scapuloperoneal spinal muscular atrophy, autosomal dominant.